Tenofovir diphosphate triethylamine
≥98%
- Product Code: 102891
CAS:
2122333-63-3
| Molecular Weight: | 548.36 g./mol | Molecular Formula: | C₁₅H₃₁N₆O₁₀P₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
Tenofovir diphosphate triethylamine is primarily used in the treatment of HIV and chronic hepatitis B infections. It functions as a nucleotide reverse transcriptase inhibitor, effectively blocking the replication of the virus by inhibiting the reverse transcriptase enzyme. This compound is a key active metabolite of tenofovir, which is commonly administered in prodrug forms such as tenofovir disoproxil fumarate. Its application is critical in antiretroviral therapy (ART) regimens, helping to reduce viral load and improve immune function in patients. Additionally, it is utilized in pre-exposure prophylaxis (PrEP) to prevent HIV infection in high-risk individuals. The triethylamine component aids in the stabilization and solubility of the compound, enhancing its pharmacokinetic properties for effective therapeutic use.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | €2,778.02 |
+
-
|
Tenofovir diphosphate triethylamine
Tenofovir diphosphate triethylamine is primarily used in the treatment of HIV and chronic hepatitis B infections. It functions as a nucleotide reverse transcriptase inhibitor, effectively blocking the replication of the virus by inhibiting the reverse transcriptase enzyme. This compound is a key active metabolite of tenofovir, which is commonly administered in prodrug forms such as tenofovir disoproxil fumarate. Its application is critical in antiretroviral therapy (ART) regimens, helping to reduce viral load and improve immune function in patients. Additionally, it is utilized in pre-exposure prophylaxis (PrEP) to prevent HIV infection in high-risk individuals. The triethylamine component aids in the stabilization and solubility of the compound, enhancing its pharmacokinetic properties for effective therapeutic use.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :